Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20718 | 388 | 37.0 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BB 10010 | Author keyword | 14 | 100% | 2% | 7 |
| 2 | CK BETA 8 | Author keyword | 11 | 100% | 2% | 6 |
| 3 | STEM CELL INHIBITOR | Author keyword | 9 | 83% | 1% | 5 |
| 4 | CCL15 | Author keyword | 8 | 75% | 2% | 6 |
| 5 | CCL23 | Author keyword | 8 | 75% | 2% | 6 |
| 6 | LEUKOTACTIN 1 | Author keyword | 8 | 62% | 2% | 8 |
| 7 | CCL18 | Author keyword | 5 | 30% | 3% | 13 |
| 8 | HCC 2 | Author keyword | 4 | 75% | 1% | 3 |
| 9 | LD78 | Author keyword | 3 | 60% | 1% | 3 |
| 10 | MIP 1 ALPHA | Author keyword | 2 | 11% | 5% | 21 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BB 10010 | 14 | 100% | 2% | 7 | Search BB+10010 | Search BB+10010 |
| 2 | CK BETA 8 | 11 | 100% | 2% | 6 | Search CK+BETA+8 | Search CK+BETA+8 |
| 3 | STEM CELL INHIBITOR | 9 | 83% | 1% | 5 | Search STEM+CELL+INHIBITOR | Search STEM+CELL+INHIBITOR |
| 4 | CCL15 | 8 | 75% | 2% | 6 | Search CCL15 | Search CCL15 |
| 5 | CCL23 | 8 | 75% | 2% | 6 | Search CCL23 | Search CCL23 |
| 6 | LEUKOTACTIN 1 | 8 | 62% | 2% | 8 | Search LEUKOTACTIN+1 | Search LEUKOTACTIN+1 |
| 7 | CCL18 | 5 | 30% | 3% | 13 | Search CCL18 | Search CCL18 |
| 8 | HCC 2 | 4 | 75% | 1% | 3 | Search HCC+2 | Search HCC+2 |
| 9 | LD78 | 3 | 60% | 1% | 3 | Search LD78 | Search LD78 |
| 10 | MIP 1 ALPHA | 2 | 11% | 5% | 21 | Search MIP+1+ALPHA | Search MIP+1+ALPHA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LEUKOTACTIN 1 | 18 | 89% | 2% | 8 |
| 2 | CHEMOKINETIC PROPERTIES | 11 | 38% | 6% | 23 |
| 3 | CHEMOKINE PARC | 11 | 78% | 2% | 7 |
| 4 | COLONY FORMATION INVITRO | 10 | 37% | 6% | 22 |
| 5 | CK BETA 8 | 9 | 83% | 1% | 5 |
| 6 | HUMAN BETA CHEMOKINE | 6 | 50% | 2% | 9 |
| 7 | MITOGENIC ACTIVATION | 6 | 53% | 2% | 8 |
| 8 | CCR1 DEPENDENT CHEMOKINES | 6 | 100% | 1% | 4 |
| 9 | PROTEIN 1 ALPHA | 5 | 24% | 5% | 19 |
| 10 | CYTOKINE LD78 | 5 | 63% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes | 2005 | 87 | 84 | 32% |
| Role of CCL18 in asthma and lung immunity | 2013 | 4 | 76 | 47% |
| Macrophage inflammatory protein-1 | 2002 | 258 | 224 | 16% |
| Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities | 1999 | 87 | 135 | 32% |
| Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15 | 2001 | 22 | 57 | 53% |
| HEMATOPOIETIC STEM-CELL INHIBITION - POTENTIAL FOR DOSE INTENSIFICATION | 1995 | 1 | 48 | 42% |
| Assays for macrophage inflammatory proteins | 1997 | 0 | 37 | 35% |
| Novel chemokines identified through bioinformatics | 1998 | 0 | 15 | 27% |
| The chemokine information source: Identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases | 1997 | 51 | 14 | 14% |
| SCI/MIP-1-ALPHA - A POTENT STEM-CELL INHIBITOR WITH POTENTIAL ROLES IN DEVELOPMENT | 1992 | 31 | 13 | 23% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT HAEMOPOIET CELL GENE THER EUT | 2 | 28% | 1.3% | 5 |
| 2 | BEIJNG P MED | 1 | 50% | 0.3% | 1 |
| 3 | BONE CARTILAGE BIOL UW2109 | 1 | 50% | 0.3% | 1 |
| 4 | CLIN MICROBIOL IMMUNOL HYGIENE | 1 | 50% | 0.3% | 1 |
| 5 | LEUKAEMIA FUNDCELLULAR DEV UNIT | 1 | 50% | 0.3% | 1 |
| 6 | ASAN LIFE SCISONGPA GU | 0 | 33% | 0.3% | 1 |
| 7 | BEIJING MIL REG | 0 | 33% | 0.3% | 1 |
| 8 | GENOME SYST BIOL PROGRAM | 0 | 33% | 0.3% | 1 |
| 9 | UNITE MIXTE RECH 8161 | 0 | 33% | 0.3% | 1 |
| 10 | CHRON METAB DIS SEVERANCE MED | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000289925 | EOTAXIN//CCR3//RANTES |
| 2 | 0.0000228035 | LYMPHOTACTIN//CTAP III//CHEMOKINE STRUCTURE |
| 3 | 0.0000168796 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
| 4 | 0.0000163046 | THYMUS AND ACTIVATION REGULATED CHEMOKINE//TARC//CCR4 |
| 5 | 0.0000138361 | CCL20//CCR6//MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA |
| 6 | 0.0000120663 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION |
| 7 | 0.0000117466 | ACSDKP//N ACETYL SERYL ASPARTYL LYSYL PROLINE//CHROMATIN PEPTIDES |
| 8 | 0.0000108639 | CXCR2//CXCR1//G31P |
| 9 | 0.0000084054 | CXCR3//CXCL10//CXCL9 |
| 10 | 0.0000082728 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |